Home

Mesothelioma

Mesothelioma Treatment

Mesothelioma Specialists

Clinical Trials

Managing Your Care

Veterans Resources

What is a New Drug Application?

Since 1938, every new drug that is ultimately marketed and sold in the US has had to file a New Drug Application (NDA), and this is the means by which a drug's sponsor asks that the Food and Drug Administration grant its approval.

The NDA must provide enough information to allow reviewers to reach the following conclusions:

Required documentation must include the complete history of the drug, from the results of animal and human testing, to what ingredients the drug contains and how it is manufactured, processed and packaged.

The chemotherapy drug, Alimta (pemetrexed), the first drug approved for malignant pleural mesothelioma, was submitted by its manufacturer, Eli Lilly & Co., under NDA #021462, and was approved on February 4, 2004.

 

The FDA process for new drugs.

 

News

Resources

 

This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information: verify here

If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:

Toll-Free 1-877-367-6376

Last updated Sat, 01/30/2010 - 13:21